Skip to Main Content

(404) 888-4444

AFFF Lawsuit

AFFF Lawsuit Status: April 2026
Over 15,200 personal injury cases are active in the AFFF MDL. Settlement negotiations are ongoing. Tier 1 cases involving long-term occupational exposure and kidney or testicular cancer carry estimated settlement ranges of $200,000 to $600,000 or more, depending on the circumstances of each case. Cases are still being reviewed. All consultations are free. No fee unless we win.

AFFF Lawsuit: Cancer Claims for Firefighters and Military Personnel Exposed to Firefighting Foam

If you worked as a firefighter, served in the military, or fought fires at an airport and were later diagnosed with cancer, you may be entitled to significant compensation through an AFFF lawsuit. Aqueous film-forming foam, known as AFFF or firefighting foam, contains toxic per- and polyfluoroalkyl substances called PFAS that have been directly linked to kidney cancer, testicular cancer, thyroid cancer, liver cancer, and several other serious conditions in people who used the foam on the job.

The manufacturers of AFFF firefighting foam, including 3M, DuPont, and Tyco Fire Products, had internal research showing these chemicals caused cancer decades before they warned anyone. More than 15,000 firefighting foam cancer lawsuits have already been filed in federal court. Settlement negotiations are underway. Our Atlanta personal injury attorneys are reviewing AFFF cancer cases nationwide. Call today for a free, confidential evaluation. Call (404) 888-4444 or fill out our quick online form for a free consultation. No fee unless we win.

What Is an AFFF Lawsuit?

An AFFF lawsuit is a personal injury case filed against the chemical manufacturers who made and sold aqueous film-forming foam while concealing decades of internal evidence that it caused cancer. These firefighting foam lawsuits are brought by firefighters, military personnel, airport workers, and industrial fire brigade members who developed cancer after years of direct occupational contact with AFFF during training exercises and emergency response.

The companies being sued, including 3M, DuPont, Chemours, Tyco Fire Products, BASF, Chemguard, National Foam, and Kidde-Fenwal, manufactured AFFF products containing PFAS and sold them to fire departments, the military, and airports for decades. Internal documents now made public through litigation show these companies knew about the cancer risks of PFAS chemicals as far back as 1949 and continued manufacturing and marketing firefighting foam without adequate warnings.

More than 15,000 firefighting foam cancer cases have been consolidated in MDL No. 2873 in the U.S. District Court for the District of South Carolina. Settlement negotiations are active as of April 2026, and attorneys involved in the litigation expect a global resolution for kidney and testicular cancer cases within 2026. State court filings remain available for new plaintiffs, and a new MDL enrollment window is anticipated once settlement terms are finalized.

AFFF Lawsuits vs. PFAS Water Contamination Lawsuits: Why These Are Different Cases

Many people researching the AFFF lawsuit have already read headlines about the $10.3 billion 3M settlement or the DuPont settlements and assume the litigation is over. Those settlements have no effect on your right to file an AFFF cancer lawsuit.

The 3M, DuPont, and BASF settlements were paid to public water systems, municipalities, and state governments to cover the cost of remediating contaminated drinking water. Not one dollar from those agreements was paid to a firefighter, military member, or airport worker who developed cancer. Those settlements did not release or bar personal injury claims by individuals who used firefighting foam directly. Your AFFF cancer claim is entirely separate and was not resolved by any settlement reported in the news.

The AFFF lawsuit targets a specific plaintiff population: people directly exposed to firefighting foam through their occupation. This is a different legal claim, against a different set of defendants, with stronger causation evidence and higher estimated individual settlement values than general PFAS water contamination cases. If you used AFFF on the job and were diagnosed with cancer, the utility settlements have no bearing on your rights.

Who Can File an AFFF Lawsuit?

To qualify for a firefighting foam lawsuit, you need two things: documented occupational exposure to AFFF and a diagnosis of a qualifying cancer or health condition. You do not need to have received official notification from your employer, the military, or any government agency. Many of the strongest AFFF cancer cases involve people who had no idea firefighting foam contained PFAS until they read about the litigation years after their diagnosis.

Career and Volunteer Firefighters

Career firefighters who used AFFF in training drills and emergency responses, volunteer firefighters who trained with or deployed the foam, and industrial fire brigade members are the core plaintiff population in the AFFF litigation. The scientific evidence connecting firefighters to elevated PFAS exposure is among the strongest in the entire case. A 2025 peer-reviewed study analyzing blood samples from over 300 firefighters found significantly higher levels of PFOS and other PFAS in firefighters compared to every other essential worker category tested, even after accounting for age, sex, and other variables.

Occupational cancer is the leading cause of death among firefighters in the United States, and AFFF exposure is now recognized as a major contributing factor. If you served as a career or volunteer firefighter for any significant period and have developed kidney cancer, testicular cancer, thyroid cancer, or another qualifying condition, your case is worth evaluating.

Military Firefighters and Veterans

The U.S. military has historically been the largest single user of AFFF, accounting for an estimated 75 percent of all firefighting foam usage in the country. Navy, Air Force, Marine Corps, and Army aviation firefighters used AFFF in routine training exercises for decades. Veterans who are unsure whether they can file a lawsuit should know that the Feres Doctrine, which limits certain claims against the U.S. government, does not apply to AFFF lawsuits. These are product liability claims against private chemical manufacturers, not the government. Veterans have the same rights as any civilian plaintiff in an AFFF cancer case.

A VA disability claim and a civil AFFF lawsuit are completely separate processes. Pursuing one does not affect the other. The compensation available through a successful civil lawsuit is typically far greater than VA disability benefits alone, and veterans should explore both avenues independently.

Airport Firefighters

From 1988 to 2018, the Federal Aviation Administration required airports to use PFAS-containing firefighting foam for aircraft crash and fuel fire response. Airport crash rescue firefighters had no choice but to use AFFF throughout that entire 30-year period because it was federally mandated. This FAA requirement gives airport firefighters one of the most clearly documented compelled exposure histories in the entire AFFF litigation. If you worked as an airport firefighter between 1988 and 2018 and developed kidney cancer, testicular cancer, thyroid cancer, or another qualifying condition, your case has a well-established and legally compelling exposure foundation.

Industrial and Fuel Industry Firefighters

Firefighters at oil refineries, petrochemical plants, fuel tank farms, and chemical processing facilities relied on AFFF as the primary agent for liquid fuel fires. Larger petroleum facilities maintained between 20,000 and 40,000 gallons of AFFF concentrate on site. Industrial fire brigade members often had more frequent direct contact with concentrated AFFF than municipal firefighters because fuel fires were an operational routine rather than an occasional emergency. The petroleum sector was also slower to phase out AFFF than airports and the military, meaning occupational exposure in this sector often continued longer.

Family Members and Wrongful Death Claims

If a firefighter, military member, or airport worker died from a cancer linked to AFFF exposure, surviving family members may have a wrongful death claim against the manufacturers. Wrongful death damages include the full projected value of the deceased’s life, medical costs before death, funeral expenses, and loss of companionship. The statute of limitations for wrongful death is typically two years from the date of death in most states. This deadline does not benefit from the discovery rule extensions that apply to personal injury claims. Contact an attorney promptly if you lost a family member to an AFFF-linked cancer.

What Is AFFF Firefighting Foam and How Does It Cause Cancer?

Aqueous film-forming foam is a chemical fire suppression agent designed to extinguish fires involving flammable liquids such as jet fuel, aviation fuel, and petroleum products. Water cannot extinguish these fires effectively because fuel floats on water and continues to burn. AFFF works by creating a thin aqueous film over the fuel surface, cutting off the oxygen supply and suppressing flammable vapors. This capability made AFFF the standard suppression agent for military aviation, commercial airports, and industrial fire operations for decades.

The PFAS chemicals that give AFFF its firefighting effectiveness are the same chemicals that cause cancer in people exposed to the foam over time. PFAS have extremely strong carbon-fluorine bonds that make them resistant to heat, water, and chemical breakdown. This is what makes AFFF so effective. It is also what makes PFAS permanently accumulate in the human body rather than being metabolized and excreted. Call (404) 888-4444 or fill out our quick online form for a free consultation. No fee unless we win.

Three Ways AFFF Firefighting Foam Enters the Human Body

AFFF exposure does not occur through a single pathway. Understanding the three documented exposure routes explains why even firefighters who wore protective gear still developed PFAS-related cancer.

Direct inhalation is the most immediate pathway. When AFFF is applied under pressure, it creates fine aerosols and chemical vapors that are inhaled during and after foam application. PFAS compounds in these aerosols are absorbed into the bloodstream through the lungs. Training exercises, where AFFF was applied repeatedly across years or decades of a career, created the highest sustained inhalation exposure.

Dermal absorption through skin contact is a second documented pathway. A 2024 peer-reviewed study published in Environmental Research confirmed that PFAS are absorbed directly through the skin when firefighters handle AFFF. Shorter-chain PFAS had the highest skin absorption rates. Even longer-chain compounds that were not directly absorbed were retained within skin tissue and released into the bloodstream gradually. This means firefighters who handled foam while wearing respiratory protection still absorbed PFAS through their skin during every training exercise.

Ingestion through contaminated water is a third relevant pathway for firefighters and military personnel who lived near training sites. AFFF applied during fire drills soaks into the ground and migrates into groundwater. Personnel who lived on or near contaminated bases and used local water for drinking and cooking received a sustained PFAS dose through ingestion in addition to their direct occupational exposure.

Why PFAS from Firefighting Foam Stays in the Body for Years

PFAS do not metabolize or break down in the human body. They accumulate in blood serum and tissue with every exposure and remain measurable for years after contact ends. Some PFAS compounds have a serum half-life of three to eight years, which means retired firefighters who stopped using AFFF a decade ago may still have elevated PFAS blood levels traceable to their career exposure. This bioaccumulation is why long-career firefighters who used AFFF across decades have the highest cancer risk and the strongest individual causation profiles.

A 2025 study published in Environmental Research analyzed blood from over 300 firefighters and found clear links between PFAS from firefighting foam and changes in microRNA expression, the molecular signals that regulate tumor suppression and immune response. The study mapped these PFAS-related changes to disease pathways for kidney cancer, bladder cancer, liver cancer, leukemia, and several autoimmune conditions. The molecular-level evidence connecting AFFF exposure to cancer continues to strengthen with every new peer-reviewed study.

Which Cancers and Health Conditions Qualify for an AFFF Lawsuit?

The AFFF MDL has organized qualifying conditions into groups based on the strength of scientific evidence and the stage of litigation readiness. Group A conditions have the strongest causation science and are the focus of the first bellwether trials. Group B conditions are on an active separate discovery track. Additional conditions continue to be added as the supporting research develops.

Kidney Cancer

Kidney cancer has the strongest scientific association with PFAS exposure of any cancer in the AFFF litigation. Multiple studies of firefighters and military personnel near AFFF training sites confirm elevated renal cell carcinoma rates compared to non-exposed populations. The first bellwether trial in the MDL was structured around kidney cancer claims, and five Pennsylvania plaintiffs with kidney cancer from Naval Air Station Willow Grove and Warminster Naval Air Weapons Center have been proposed for a consolidated bellwether proceeding.

Kidney cancer cases carry strong compensation potential because treatment frequently involves surgical removal of a kidney, recovery is prolonged, the remaining kidney bears increased lifelong functional demand, and fear of recurrence substantially diminishes quality of life for decades. Long-career firefighters with documented AFFF use and kidney cancer diagnoses are Tier 1 cases with estimated settlement values of $200,000 to $600,000.

Testicular Cancer

Testicular cancer has a particularly strong documented link to PFOS, the primary PFAS compound in 3M’s AFFF products. A 2023 study of 530 U.S. Air Force members diagnosed with testicular cancer found elevated PFOS blood levels in every single tested subject compared to service members without the diagnosis. A second confirming study published later that year was described by one plaintiff attorney as the strongest proof yet of the AFFF-testicular cancer connection.

Testicular cancer in the AFFF litigation frequently affects younger men in their 20s and 30s with no family history of cancer and no other recognized risk factors. This profile makes causation arguments cleaner than many other cancer types and drives projected lifetime damages higher because of the younger plaintiff’s remaining working years and life expectancy. AFFF testicular cancer cases are among the highest-value claims in the current litigation.

Thyroid Cancer and Thyroid Disease

Both thyroid cancer and serious thyroid disease, including hypothyroidism, hyperthyroidism, and Hashimoto’s disease, are qualifying conditions in the AFFF litigation. PFAS disrupt thyroid hormone production at the molecular level, affecting metabolism, energy, immune function, and reproductive health. These conditions appear more frequently in female firefighters, military spouses who lived near contaminated bases, and airport workers.

Thyroid disease and thyroid cancer are Group B conditions in the MDL. Their dedicated discovery track completed in April 2026, and these cases are now advancing toward trial selection. The June 2025 Science Day in the MDL specifically addressed the causation evidence for thyroid cancer, with plaintiff expert reports already submitted to the court and defendant responses pending.

Liver Cancer

Liver cancer is a Group A qualifying condition in the AFFF MDL. The Science Day held in June 2025 presented expert causation evidence for liver cancer directly to Judge Gergel, advancing the scientific record for these cases within the litigation. Liver cancer cases typically involve later-stage diagnosis, aggressive treatment, and significant economic and non-economic damages. AFFF liver cancer lawsuits are an active track within the MDL moving toward settlement resolution.

Ulcerative Colitis

Ulcerative colitis is not a cancer but is one of the most established qualifying conditions in the firefighting foam litigation. The link between PFAS exposure and ulcerative colitis was among the original probable associations identified by the DuPont-funded C8 Science Panel study of 69,000 exposed residents. Ulcerative colitis is a chronic inflammatory bowel disease requiring lifelong management including daily medication, frequent colonoscopies, and in serious cases surgical removal of part or all of the colon.

Ulcerative colitis is the most active Group B case category in the current MDL. Three additional plaintiffs were added to the discovery pool in September 2025, and their Tier 2 discovery track is advancing toward expert testimony and potential trial. For firefighters with long documented AFFF exposure and an ulcerative colitis diagnosis, these cases are in active litigation.

Additional Qualifying Conditions

Bladder cancer, prostate cancer, breast cancer, leukemia, non-Hodgkin’s lymphoma, multiple myeloma, and uterine cancer all appear in the expanded qualifying conditions being evaluated in the AFFF litigation. The Firefighter PFAS Injury Compensation Act, bipartisan federal legislation introduced in 2024, specifically lists prostate cancer, breast cancer, pancreatic cancer, and bladder cancer as additional qualifying conditions alongside the core Group A diagnoses. If you are a firefighter or military member with any of these diagnoses and a documented AFFF exposure history, a case evaluation is warranted.

Who Made AFFF? The Defendants in Firefighting Foam Lawsuits

AFFF lawsuits name the companies that manufactured and sold firefighting foam containing PFAS while concealing internal evidence of the cancer risk. These are not suits against fire departments, military branches, or airport operators. Those employers were themselves often deceived by the manufacturers. The defendants are the private chemical companies that had a duty to warn and chose not to.

3M Company

3M was for many years the world’s primary manufacturer of PFOS and PFOA, the PFAS compounds at the core of AFFF. The company’s internal documents, published by The Guardian in a 2025 investigation, include 1978 meeting minutes explicitly noting that certain PFAS chemicals should be regarded as toxic. Evidence that PFAS do not break down in the environment was available internally at 3M as early as 1949. The company continued full-scale AFFF production and sold firefighting foam to the military, airports, and fire departments for decades after these findings were internally documented. 3M agreed to a $10.3 billion water utility settlement in 2023 that resolved remediation costs only and did not resolve AFFF personal injury claims.

Tyco Fire Products and Johnson Controls

Tyco Fire Products manufactures Ansulite AFFF and continues to produce fluorinated firefighting foams as a subsidiary of Johnson Controls. Tyco and Johnson Controls agreed to a $750 million settlement with public water systems in 2024, which covered water remediation costs. Personal injury claims by firefighters and military personnel against Tyco Fire Products remain active in the AFFF MDL.

National Foam and Kidde-Fenwal

National Foam, now part of Kidde-Fenwal, has produced fluorinated firefighting foams since 1965. Kidde-Fenwal filed for Chapter 11 bankruptcy in May 2023 after being named in more than 4,400 AFFF lawsuits. Carrier Global, the parent company, agreed to a $730 million settlement in 2024 to resolve PFAS claims through the bankruptcy process, creating a fund to compensate people harmed by Kidde-Fenwal firefighting foam products.

BASF Corporation

BASF agreed to a $316.5 million settlement with public water systems in May 2024 covering PFAS water contamination remediation costs. This utility settlement did not resolve personal injury claims by firefighters and military members. BASF remains a named defendant in the AFFF MDL for personal injury cases.

DuPont, Chemours, Chemguard, and Buckeye Fire Equipment

DuPont and its spinoff Chemours manufactured PFAS compounds used in AFFF formulation and face ongoing personal injury litigation in the MDL. Chemguard continues to manufacture fluorinated firefighting foams and is a named defendant. Buckeye Fire Equipment produces legacy and current AFFF products. As the litigation progresses, additional manufacturers and formulators are being named based on specific product identification for each plaintiff’s documented exposure history.

What 3M and DuPont Knew About AFFF Dangers and When They Knew It

The strength of the AFFF lawsuit comes not only from the science linking firefighting foam to cancer but from documented proof that the manufacturers knew about this link for decades before warning the public. The internal corporate records made public through litigation discovery are the foundation for punitive damages claims and the primary reason defendants strongly prefer settlement to jury trial.

Evidence available internally at 3M as early as 1949 showed that PFAS do not break down in the environment. By the 1970s, 3M scientists were tracking PFOS accumulation in workers’ blood. The 1978 internal meeting minutes published by The Guardian in 2025 explicitly stated that certain PFAS chemicals should be regarded as toxic. 3M continued full-scale AFFF production and sold firefighting foam to the military, airports, and fire departments for decades after these findings were documented internally.

DuPont’s concealment is equally documented in the public record. The company funded a seven-year health study of 69,000 residents near its Washington Works plant, received findings confirming probable links between PFOA and six diseases including kidney cancer and testicular cancer, and continued manufacturing without warning anyone. These documents have been presented in court proceedings, and they make defendants face the prospect of having a jury read their own scientists’ warnings about toxicity while they continued selling the product. That prospect drives settlement negotiations more than any other single factor.

The AFFF MDL: What Firefighters Need to Know About the Federal Lawsuit

The AFFF multidistrict litigation, formally MDL No. 2873, is the coordinated federal proceeding that brings together all AFFF personal injury cases before a single judge for pretrial proceedings. Understanding how the MDL works helps you set accurate expectations for your firefighting foam lawsuit.

Is the AFFF Lawsuit a Class Action?

No. The AFFF MDL is not a class action, and this distinction matters significantly to plaintiffs. In a class action, all plaintiffs share a single settlement divided among members. In the AFFF MDL, each plaintiff keeps their individual case with their own damages, their own medical records, their own employment history, and their own attorney representing exclusively their interests. The MDL coordinates the pretrial discovery work that is common across all cases, so every plaintiff benefits from shared depositions of corporate executives, shared production of internal company documents, and shared expert witnesses in toxicology and oncology. Your case is your own.

Current Status of the AFFF Lawsuit: April 2026

As of April 2026, there are 15,222 personal injury cases pending in the AFFF MDL before Judge Richard M. Gergel. Settlement negotiations are active. Judge Gergel has publicly urged the defendants, including 3M, DuPont, BASF, and Johnson Controls, to settle these cases before bellwether trials proceed. Both sides are engaging with a mediator in confidential discussions. Attorneys familiar with the litigation believe a global settlement resolving kidney and testicular cancer cases is likely in 2026, following the same pattern of pre-trial resolution that occurred with the water utility defendants.

Bellwether Trials: Why They Determine Your Settlement Value

A bellwether trial is a test case selected to go before a jury first. The AFFF MDL is focused on kidney cancer claims for the first bellwether trial, with a motion pending to consolidate five Pennsylvania plaintiffs with kidney and testicular cancer from Naval Air Station Willow Grove and Warminster Naval Air Weapons Center. The October 2025 trial date was postponed after the surge of new filings following Judge Gergel’s 21-day filing window, and has not yet been rescheduled.

A plaintiff verdict in the first bellwether trial, and the size of the award, directly sets the value framework for all remaining kidney cancer cases in the MDL. This is why defendants prefer to settle before bellwether verdicts create a precedent that applies across thousands of cases. Building your case before the bellwether verdict positions you to benefit from whatever value the trial establishes.

The September 2025 Filing Window: What New Plaintiffs Need to Know

In August 2025, Judge Gergel issued Case Management Order No. 35 creating a 21-day window for all pending AFFF personal injury cases to be formally filed into the MDL. That window closed September 5, 2025, and resulted in 37,446 new claims being filed. Standard new filings into the current MDL phase are paused.

This does not mean the opportunity to pursue an AFFF cancer lawsuit is closed. State court filings remain viable in most jurisdictions for AFFF personal injury cases independent of the MDL. When a global settlement is reached, a formal claims administration process typically opens a new enrollment window for eligible claimants. Cases being evaluated and documented now will be ready to enter that process immediately when it opens, which is far better than starting the documentation process after the announcement.

AFFF Lawsuit Settlement Amounts: What Are Firefighting Foam Cases Worth?

Settlement amounts in AFFF firefighting foam lawsuits will vary based on the severity of your diagnosis, the length and intensity of your AFFF exposure, your age and projected lifetime damages, the specific defendants responsible, and whether your case is resolved individually or through a global MDL settlement. The following estimates are based on the tiered structure that attorneys involved in the litigation expect the AFFF settlement to follow.

Tier 1 Cases: $200,000 to $600,000

Tier 1 AFFF cases represent the strongest plaintiff profiles. A career firefighter with 20 or more years of documented AFFF training exposure who developed kidney cancer or testicular cancer in their 40s or 50s is a Tier 1 plaintiff. The combination of long occupational AFFF exposure, the established causation science for kidney and testicular cancer specifically, and the significant projected lifetime damages from a serious cancer diagnosis in a middle-aged plaintiff drives values toward the upper range. Airport firefighters who worked under the FAA mandate from 1988 to 2018 and military firefighters with documented service records at contaminated installations also reach this tier when paired with a qualifying diagnosis.

Tier 2 Cases: $150,000 to $200,000

Tier 2 AFFF cases involve qualifying diagnoses with shorter or less fully documented exposure histories, or conditions where the causation science is solid but not as deeply established as for kidney or testicular cancer. A firefighter with significant but shorter AFFF exposure, or a plaintiff with thyroid cancer, liver cancer, or ulcerative colitis as the primary diagnosis, typically falls into this range.

Tier 3 Cases: Under $75,000

Tier 3 cases involve limited documented exposure periods, conditions with less developed causation evidence, or factual profiles where alternative explanations for the diagnosis are harder to rule out. These cases carry value but will receive lower allocations in a structured global settlement.

Past Settlements That Signal What Defendants Will Pay

The defendants in the AFFF MDL have already demonstrated they will pay billions rather than face jury trials. The $10.3 billion 3M water utility settlement, the $750 million Tyco and Johnson Controls utility settlement, the $730 million Carrier Global bankruptcy settlement, the $316.5 million BASF settlement, and the $1.185 billion DuPont, Chemours, and Corteva settlement all reflect the same preference: pay to settle rather than let juries hear the internal documents showing what these companies knew and when they knew it. Every water utility settlement adds precedent pressure on defendants when personal injury bellwether trials approach.

The Firefighter PFAS Injury Compensation Act: A Parallel Compensation Track

The Firefighter PFAS Injury Compensation Act is bipartisan federal legislation introduced by Senator Cory Booker that would create a federal compensation program for firefighters with PFAS-related illnesses, completely separate from the civil AFFF lawsuit process. The bill covers kidney cancer, testicular cancer, liver cancer, thyroid cancer, qualifying thyroid disease, and ulcerative colitis as primary qualifying conditions, and adds prostate cancer, breast cancer, pancreatic cancer, and bladder cancer as additional covered conditions.

This federal program would be a parallel avenue for compensation, not a replacement for your lawsuit. Filing an AFFF cancer lawsuit now preserves your rights under both tracks. The legislation has not yet passed and faces budget pressures in the current Congress, but it represents a meaningful additional compensation path that firefighters should monitor actively.

Firefighter Turnout Gear and PFAS Cancer: A Separate Lawsuit Track

Every firefighter who wore protective gear in the past several decades was exposed to PFAS chemicals, even if they never personally applied AFFF foam. This is one of the most important and most underreported aspects of current PFAS litigation, and it significantly broadens the population eligible to pursue PFAS-related cancer claims.

Firefighter turnout gear, also called bunker gear or protective clothing, is treated with PFAS-based coatings to provide the moisture and heat resistance that makes the gear effective. The same chemical properties that protect firefighters from heat on the outside are absorbed through the skin during wear. Studies have documented PFAS in the blood of firefighters who have never personally used AFFF foam, at levels consistent with sustained dermal absorption from years of wearing PFAS-treated protective equipment.

The 2024 Connecticut firefighters’ proposed class action focused exclusively on turnout gear rather than AFFF foam and may be the first major case of its kind. Case Management Order No. 5F in the AFFF MDL established a separate plaintiff fact sheet process specifically for turnout gear claims, confirming that the court treats these as a distinct case category with their own defendant set and their own discovery track.

Turnout gear PFAS cancer lawsuits are filed against the manufacturers of the gear itself rather than the AFFF foam companies. A firefighter can pursue both a firefighting foam claim against companies like 3M and Tyco and a turnout gear claim against gear manufacturers at the same time. These are separate exposure pathways against different defendants, and they do not conflict with each other. If you wore PFAS-treated firefighter protective gear throughout your career and developed cancer, a turnout gear cancer claim may be viable for you regardless of whether you directly handled foam.

AFFF Lawsuits for Veterans and Military Personnel: A Complete Guide

Military firefighters and veterans represent the largest single segment of the AFFF plaintiff population. Their circumstances involve unique legal considerations that deserve direct answers.

Can Veterans File AFFF Lawsuits Against the Manufacturers?

Yes. The legal barrier most veterans assume prevents them from filing does not apply to AFFF cases. The Feres Doctrine bars active duty military members from suing the U.S. government for service-related injuries. AFFF lawsuits are not suits against the government. They are product liability claims against private chemical manufacturers including 3M, DuPont, Tyco Fire Products, and BASF that made and sold firefighting foam while concealing its health risks. The Feres Doctrine has no bearing on these claims.

Veterans who served at any military installation where AFFF was used in fire training or emergency response and who developed kidney cancer, testicular cancer, thyroid cancer, or another qualifying condition have the same legal rights as any civilian plaintiff to pursue a firefighting foam cancer lawsuit against the manufacturers.

Can a VA Disability Claim and an AFFF Lawsuit Run at the Same Time?

Yes. These are entirely separate processes, and pursuing one does not affect the other. A VA disability claim is evaluated on service connection and disability rating. A civil AFFF lawsuit seeks full damages from the manufacturers, including past and future medical costs, lost income, pain and suffering, and potentially punitive damages based on corporate concealment. The compensation available through a successful AFFF lawsuit is typically substantially greater than VA benefits alone. Veterans who already have a VA rating for a PFAS-related cancer should explore their civil lawsuit options independently.

Key Military Installations With Documented AFFF Contamination

Veterans who served at any of the following installations and developed qualifying cancers have documented exposure pathways that form the foundation of viable AFFF cancer lawsuits:

  • Naval Air Station Willow Grove and Warminster Naval Air Weapons Center, Pennsylvania (currently central to MDL bellwether selection)
  • Robins Air Force Base, Warner Robins, Georgia
  • Fort Stewart and Hunter Army Airfield, Hinesville and Savannah, Georgia
  • Fort Moore, Columbus, Georgia
  • Moody Air Force Base, Valdosta, Georgia
  • Eglin Air Force Base, Valparaiso, Florida
  • NAS Pensacola, Pensacola, Florida
  • NAS Jacksonville, Florida
  • Tinker Air Force Base, Oklahoma City, Oklahoma
  • Travis Air Force Base, Fairfield, California
  • Peterson Space Force Base, Colorado Springs, Colorado
  • Camp Lejeune, Jacksonville, North Carolina
  • McChord Air Force Base, Tacoma, Washington

Hundreds of additional military installations have been identified in EPA and DoD contamination records. If you served at a base not listed here, a site-specific review of available contamination documentation is part of the case evaluation process.

How to File an AFFF Lawsuit: Step by Step

Filing a firefighting foam cancer lawsuit does not require you to manage a complicated legal process on your own. Here is what the path from your first call to resolution actually looks like.

Step 1: Free Case Evaluation

You contact our firm and share your occupational history involving firefighting foam, your diagnosis, and when it was made. This costs nothing and commits you to nothing. Everything you share is protected by attorney-client confidentiality from the first conversation. We assess your information and give you an honest evaluation of whether your case has merit.

Step 2: Medical and Employment History Investigation

If your case has merit, your attorney gathers your medical records confirming the diagnosis and documents your AFFF exposure history using fire department records, military service records, airport employment records, and facility documentation of AFFF use. If PFAS blood testing has not been done and would add value to your causation evidence, we can coordinate that through a commercial lab.

Step 3: Filing Strategy

Your attorney determines the optimal filing approach based on your facts: state court in a favorable jurisdiction, or positioning for the next MDL enrollment window. Cases can be fully prepared and documented while current settlement negotiations continue, so you are ready to file the moment an opportunity opens.

Step 4: Discovery and Expert Development

Your attorney builds the causation case connecting your AFFF exposure, the specific manufacturer whose product you used, and your cancer diagnosis. Expert witnesses in toxicology, occupational medicine, and oncology establish the causal link. In MDL cases, the core expert infrastructure and corporate document discovery are already developed and available from the shared MDL proceedings.

Step 5: Settlement or Trial

The large majority of AFFF cancer cases are expected to resolve through negotiated settlement. We prepare every case as though it will go to trial because defendants settle the cases they believe they will lose. If a fair settlement is not reached, your case proceeds to trial with full preparation.

No Fee Unless We Win
All AFFF firefighting foam cancer cases are handled on a contingency fee basis. You pay no attorney fees unless we recover compensation for you. Case costs including expert witnesses, filing fees, and medical records are advanced by the firm and recovered from the settlement or verdict. If your case does not succeed, you owe nothing.

How Long Do You Have to File an AFFF Lawsuit?

The deadline to file an AFFF cancer lawsuit varies by state and typically ranges from one to four years. In most states, the clock starts not from the date of your AFFF exposure but from the date of discovery, meaning when you knew or reasonably should have known your cancer may have been linked to firefighting foam exposure. This discovery rule is particularly important in AFFF cases because widespread public awareness of the AFFF-cancer connection only emerged after the major settlements made national headlines in 2023 and 2024.

A firefighter diagnosed with kidney cancer in 2019 who only connected that diagnosis to his career AFFF use in 2023 after reading about the MDL may have had his discovery date in 2023, keeping his case well within the limitations period despite the years that passed since diagnosis. Do not assume your case is time-barred before speaking with a personal injury attorney. Many firefighters with valid AFFF cancer lawsuits make that assumption incorrectly. Call (404) 888-4444 or fill out our quick online form for a free consultation. No fee unless we win.

State Statute of Limitations AFFF Notes
Georgia 2 years Discovery rule applies. Robins AFB, Fort Stewart, Fort Moore documented contamination sites.
Pennsylvania 2 years NAS Willow Grove and Warminster are core MDL bellwether sites. High litigation activity.
Florida 4 years Eglin AFB and NAS Pensacola key exposure sites. Longer SOL preserves more claims.
North Carolina 3 years Camp Lejeune and multiple Air Force bases. CLJA process also available for Lejeune specifically.
California 2 years Multiple Navy, Air Force, and Marine Corps installations with documented contamination.
Texas 2 years Multiple Air Force and naval installations. Growing AFFF firefighter litigation.
Colorado 2 years Peterson SFB, Buckley SFB, and Schriever AFB documented contamination.
Michigan 3 years Camp Grayling, Wurtsmith AFB, Selfridge ANGB documented.
New Hampshire 3 years Pease AFB was one of the first documented AFFF contamination sites nationally.
Washington 3 years McChord AFB and Whidbey Island NAS documented AFFF contamination.
Ohio 2 years Multiple Air National Guard installations. Discovery rule supported.
New Jersey 2 years Naval Air Station Lakehurst and industrial AFFF exposure sites.

 

Important
This table is a general reference. The applicable statute of limitations and how the discovery rule applies to your specific case depend on your state’s law and the facts of your situation. Do not conclude your case is time-barred without first consulting an attorney.

Frequently Asked Questions About AFFF Lawsuits

What is the difference between an AFFF lawsuit and a PFAS water contamination lawsuit?

An AFFF lawsuit is a personal injury case filed by firefighters, military personnel, and airport workers who were directly exposed to firefighting foam on the job and developed cancer. A PFAS water contamination lawsuit is typically filed by residents or water utilities affected by PFAS in their drinking water supply. These are separate legal cases with different defendants and different causation frameworks. The $10.3 billion 3M settlement and the DuPont settlements resolved water contamination cleanup costs only. They did not compensate any firefighter or military member who developed cancer from AFFF exposure, and they have no effect on an AFFF cancer lawsuit.

Can I still file an AFFF lawsuit if the September 2025 MDL filing window has closed?

Yes. The September 2025 MDL filing window closed after more than 37,000 new claims were submitted, and standard new filings into the current MDL phase are paused. However, AFFF personal injury cases can still be filed in state court in most jurisdictions independent of the MDL window. When the global settlement negotiations produce a final agreement, the court will establish a claims administration process that opens a new enrollment window for eligible plaintiffs. Cases that are fully prepared and documented at that point will be able to enter the process immediately, which is the most important reason to begin the evaluation process now.

Do I need to prove I personally used AFFF foam to file a lawsuit?

You need to show a plausible documented exposure pathway, but this does not require direct video evidence of you personally applying foam. Fire department training records, military service assignment records, airport employment records, and testimony about standard operating procedures at your facilities all establish exposure. Many plaintiffs have not seen their own PFAS blood test results when they initially contact an attorney. Gathering and organizing the exposure evidence is handled by your legal team after you make the first contact.

Are airport firefighters eligible to file AFFF cancer lawsuits?

Yes, and airport firefighters have some of the most clearly documented compelled exposure histories in the entire AFFF litigation. The FAA required airports to use PFAS-containing firefighting foam from 1988 to 2018, a 30-year federal mandate that gave airport crash rescue firefighters no option to avoid AFFF. Every airport firefighter who worked under that mandate and later developed kidney cancer, testicular cancer, thyroid cancer, or another qualifying condition has an exposure history rooted in federal regulatory requirement, making the causation argument particularly difficult for defendants to contest.

Can my firefighter turnout gear exposure support a separate lawsuit?

Yes. Firefighter protective gear is treated with PFAS-based coatings that have been documented to absorb through the skin. The AFFF MDL established a separate plaintiff fact sheet process for turnout gear claims through Case Management Order No. 5F, treating these as a distinct case category with their own defendants. A firefighter can pursue both an AFFF foam claim and a separate turnout gear PFAS claim simultaneously because these are different exposure pathways against different manufacturers. If you wore PFAS-treated protective gear throughout your career and developed cancer, a turnout gear claim may be viable for you even if you never directly handled foam.

Can veterans sue for AFFF cancer?

Yes. The Feres Doctrine bars certain lawsuits against the U.S. government for service-related injuries, but AFFF lawsuits are product liability claims against private manufacturers like 3M, Tyco Fire Products, and DuPont. The Feres Doctrine does not apply. Veterans have the same legal rights as any civilian plaintiff in an AFFF cancer case. A VA disability claim and a civil AFFF lawsuit are independent processes that can proceed at the same time. The compensation available through a civil lawsuit is typically far greater than VA benefits alone.

What if my fire department or the military never warned me that AFFF contained PFAS?

This describes the situation the vast majority of AFFF plaintiffs are in, and it does not prevent you from filing a lawsuit. Fire departments, airports, and the military purchased AFFF and used it as directed, unaware of the health risks, because the manufacturers chose to conceal those risks rather than warn anyone. The legal liability for that concealment belongs to the companies that made and marketed AFFF knowing it was dangerous. The absence of any warning you received is actually evidence of the manufacturers’ failure to fulfill their duty, not a barrier to your claim.

What cancers qualify for an AFFF lawsuit?

The primary qualifying conditions in the AFFF MDL are kidney cancer, testicular cancer, thyroid cancer, thyroid disease including hypothyroidism and Hashimoto’s disease, liver cancer, and ulcerative colitis. Bladder cancer, prostate cancer, breast cancer, leukemia, non-Hodgkin’s lymphoma, multiple myeloma, and uterine cancer are additional conditions being evaluated as the supporting science continues to develop. If you are a firefighter or military member with a cancer diagnosis and documented AFFF exposure and your specific condition is not listed here, an evaluation is still worthwhile because the qualifying conditions list continues to expand.

What are AFFF settlement amounts expected to be per person?

AFFF lawsuit settlement amounts are estimated by case tier. Tier 1 cases involving long-term career AFFF exposure and kidney or testicular cancer are estimated at $200,000 to $600,000 per plaintiff. Tier 2 cases with significant but shorter documented exposure or Tier 2 diagnoses are estimated at $150,000 to $200,000. Tier 3 cases are estimated below $75,000. These estimates reflect the litigation trajectory as of April 2026 and may increase if bellwether trial verdicts are favorable to plaintiffs. The specific value of your individual case depends on your diagnosis, exposure duration, age, and the defendants responsible.

How long does an AFFF firefighting foam lawsuit take?

The timeline depends on whether your case resolves through a global MDL settlement or proceeds individually. Attorneys involved in the AFFF litigation believe a global settlement resolving kidney and testicular cancer cases is likely in 2026. After a global settlement is reached, the claims administration and payment process typically takes several months to complete. Individual state court cases may resolve on a different timeline depending on the jurisdiction, defendant, and specific facts. Your attorney will give you a realistic timeline assessment based on the current state of the litigation at the time of your evaluation.

Is the Firefighter PFAS Injury Compensation Act a replacement for filing an AFFF lawsuit?

No. The Firefighter PFAS Injury Compensation Act is bipartisan federal legislation that would establish a separate federal compensation program for firefighters with PFAS-related conditions, independent of the civil litigation. If passed, it would provide an additional compensation avenue. Filing an AFFF cancer lawsuit now preserves your rights under both tracks because the civil lawsuit and the federal compensation program operate independently of each other. The legislation has not yet passed, but monitoring its progress is worthwhile because it represents a parallel path to compensation that does not require waiting for the civil litigation to conclude.

Can the family of a firefighter who died from cancer file an AFFF wrongful death claim?

Yes. If a firefighter, military member, or airport worker died from a cancer linked to AFFF exposure, the surviving spouse, children, or parents may file a wrongful death lawsuit against the manufacturers responsible for their AFFF exposure. Wrongful death damages include the full projected value of the deceased’s life, medical costs and pain and suffering before death, funeral expenses, and loss of companionship for surviving family members. The statute of limitations for wrongful death is typically two years from the date of death in most states and does not benefit from the discovery rule extensions that apply to personal injury claims. Contact an attorney promptly if you lost a family member to a firefighting foam-related cancer.

Free Case Evaluation for Firefighters and Military Personnel Exposed to AFFF

If you served as a career or volunteer firefighter, military firefighter, airport crash rescue worker, or industrial fire brigade member and have been diagnosed with kidney cancer, testicular cancer, thyroid cancer, liver cancer, ulcerative colitis, or another qualifying condition, you may have an AFFF cancer lawsuit worth pursuing.

We review firefighting foam cancer cases nationwide. Every consultation is free and completely confidential. There is no fee unless we recover compensation for you. The anticipated 2026 AFFF settlement will create a filing window that rewards plaintiffs who are already prepared. The time to evaluate your case is now.

Statutes of limitations vary by state. The sooner you speak with an attorney, the better your ability to document your exposure, preserve your employment records, and protect your legal rights. Call us today for a free, no-obligation AFFF cancer case review. Call (404) 888-4444 or fill out our quick online form for a free consultation. No fee unless we win.

🇺🇸 English 🇪🇸 Español 🇰🇷 한국어